Investigating the Use of Goal Management Therapy in Improving Cognitive Functioning in Public Safety Personnel With PTSD
Launched by HOMEWOOD RESEARCH INSTITUTE · Jan 29, 2020
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a type of therapy called Goal Management Therapy (GMT) to see if it can help improve thinking skills in public safety personnel who are dealing with post-traumatic stress disorder (PTSD). PTSD can make it hard for people to focus and complete tasks, and GMT is designed to help improve these abilities by training the brain to better manage goals and tasks.
To take part in this study, participants need to be between the ages of 18 and 65 and have a diagnosis of PTSD confirmed by a specific assessment tool. They also need to be able to give written consent to participate. However, individuals who are currently taking certain medications, have had specific medical treatments recently, or have certain medical or mental health conditions may not be eligible. If you decide to participate, you will receive the GMT therapy and be monitored over the course of the study to see how it impacts your cognitive function. This trial is currently recruiting participants, and it aims to provide valuable insights into helping those affected by PTSD.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • have a diagnosis of post-traumatic stress disorder on the Clinician Administered PTSD Scale (CAPS)
- • are able to provide written informed consent
- Exclusion Criteria:
- • receiving treatment with anti-cholinergics, anti-psychotic medication, or psychostimulants
- • use of benzodiazepines within the last 24 hours
- • have had Electroconvulsive therapy within the past year
- • a diagnosis of substance dependence or abuse within the past 6 months
- • a recent history (within the past 12 months) of medical disorder known to adversely affect cognition
- • a history of head trauma with more than one minute of loss of consciousness or a history of traumatic brain injury
- • a history of neurological disorder
- • a diagnosis of psychotic disorder or bipolar disorder
- • a history of a neurodevelopmental disorder
About Homewood Research Institute
Homewood Research Institute is a leading organization dedicated to advancing mental health research and improving treatment outcomes for individuals affected by mental health disorders. Committed to innovative scientific inquiry, the Institute collaborates with academic institutions, healthcare providers, and community organizations to conduct rigorous clinical trials. Its mission is to translate research findings into effective therapeutic interventions, enhance the understanding of mental health conditions, and foster evidence-based practices that promote recovery and well-being. Through a patient-centered approach, Homewood Research Institute strives to make a meaningful impact on the lives of individuals and families facing mental health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guelph, Ontario, Canada
Patients applied
Trial Officials
Margaret McKinnon, PhD
Principal Investigator
McMaster University, St. Joseph's Healthcare Hamilton, Homewood Research Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials